J Korean Med Sci.  2010 Jan;25(1):90-96. 10.3346/jkms.2010.25.1.90.

Immunogenicity of Haemophilus influenzae Type b Conjugate Vaccines in Korean Infants: A Meta-analysis

• Lee H
• Hahn S
• Lee HJ
• Kim KH

• KMID: 1713837
• DOI: http://doi.org/10.3346/jkms.2010.25.1.90

Abstract

A meta-analysis was performed on the immunogenicity of Haemophilus influenzae type b (Hib) conjugate vaccines after 2 (2 and 4 months) and 3 doses (2, 4, and 6 months) in Korean infants. A database search of MEDLINE, KoreaMed, and Korean Medical Database was done. The primary outcome measure was the proportion of infants with anti-polyribosylribitol phosphate (PRP) concentrations > or =1.0 microgram/mL. Eight studies including eleven trials were retrieved. One trial reported on the diphtheria toxoid conjugate vaccine (PRP-D) and 2 trials each on the mutant diphtheria toxin (PRP-CRM) and Neisseria meningitidis outer-membrane protein (PRP-OMP) conjugate vaccine. Heterogeneity in study designs between trials on PRP-CRM was noted and one trial reported on a monovalent and another on a combination PRP-OMP vaccine. Thus, a meta-analysis was conducted only on the tetanus toxoid conjugate vaccine (PRP-T). After a primary series of 2 doses and 3 doses, 80.6% (95% confidence interval [CI]; 76.0-85.1%) and 95.7% (95% CI; 94.0-98.0%) of infants achieved an antibody level > or =1.0 microgram/mL, respectively. The immunogenic response to the PRP-T vaccine was acceptable after a primary series of 3 doses and also 2 doses. A reduced number of doses as a primary series could be carefully considered in Korean infants.

Keyword

Haemophilus influenza type b; Vaccines; Immunity; Meta-analysis

MeSH Terms

Antibodies/analysis
Bacterial Capsules/*immunology/metabolism
Haemophilus Vaccines/*immunology/metabolism
Humans
Infant
Republic of Korea
Tetanus Toxoid/chemistry/metabolism
Vaccines, Conjugate/immunology/metabolism
Antibodies
Haemophilus Vaccines
Tetanus Toxoid
Vaccines, Conjugate